InnovAge (INNV) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
21 May, 2026Business model and market positioning
Operates a fully integrated, full-risk payor-provider platform focused on frail, medically and socially complex seniors, enabling them to live independently and avoid nursing homes.
Delivers comprehensive, interdisciplinary care through 20 centers across 6 states, serving over 8,000 participants, with a scalable, center-based model.
Targets high-acuity, dual-eligible seniors, leveraging a vertically integrated approach for end-to-end accountability and cost control.
Positioned as the only scaled, multi-state PACE platform with advanced technology and operating capabilities.
Benefits from strong bipartisan policy support and demographic tailwinds, with a large, underpenetrated addressable market of 2.3 million eligible lives and a $265B core market.
Operational performance and financial highlights
Achieved a 13.5% revenue CAGR from 3QFY23 to 3QFY26, with total revenues rising from $172.5M to $251.9M quarterly.
Adjusted EBITDA margin improved to 12.1% in 3QFY26, with trailing twelve-month adjusted EBITDA reaching $81.6M.
Center-level contribution margin expanded to 21.8% as of March 31, 2026, reflecting operational leverage and efficiency gains.
Generated $52.4M in operating cash flow (TTM), supporting ongoing investments and growth.
Fiscal 2026 guidance projects 7,900–8,100 census, $950M–$975M revenue, and $85M–$90M adjusted EBITDA.
Care model and outcomes
Provides high-touch, personalized care with small PCP panel sizes (<100), frequent participant interactions, and a concierge practice model.
Serves a population with an average risk adjustment factor of 2.42, multiple chronic conditions, and high medication needs.
Achieves superior outcomes: 10% lower inpatient admission rates, 40% lower 30-day readmission rates, and 12% lower costs compared to Medicaid benchmarks.
Maintains voluntary disenrollment rates less than half those of Medicare Advantage plans.
Over 92% of participants remain independent, with robust support for activities of daily living.
Latest events from InnovAge
- Registering 112.99M shares for resale by holders; largest PACE provider with recurring revenue.INNV
Registration filing - Revenue and margins rose 15.5%, but net loss increased due to litigation and compliance costs.INNV
Q3 2026 - Integrated care model drives growth, margin expansion, and superior outcomes for complex seniors.INNV
Corporate presentation - Q2 revenue and margins surged, raising full-year guidance despite ongoing cost and regulatory risks.INNV
Q2 2026 - Integrated care model and tech investments drive growth, margin gains, and superior outcomes.INNV
44th Annual J.P. Morgan Healthcare Conference - Care coordination, trust, and tailored technology are key to advancing aging-in-place models.INNV
7th Annual Healthcare Symposium - Revenue up 12.4%, Adjusted EBITDA up fivefold, and net loss narrowed to $5.7 million.INNV
Q1 2025 - Revenue up 11% with margin gains and positive Adjusted EBITDA; 2025 outlook remains strong.INNV
Q4 2024 - Revenue up 13% but net loss widened; Adjusted EBITDA and 2025 guidance improved.INNV
Q3 2025